Gene expression in WAT from healthy humans and monkeys correlates with FGF21-induced browning of WAT in mice

Obesity

Volumn 23, Issue 9, 2015, Pages 1818-1829

  Schlessinger, Karni ^a   Li, Wenyu ^a   Tan, Yejun ^a   Liu, Franklin ^a   Souza, Sandra C ^a   Tozzo, Effie ^a   Liu, Kevin ^a   Thompson, John R ^a   Wang, Liangsu ^a   Muise, Eric S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR; MICRORNA; TRANSCRIPTOME;

ADIPOCYTE; ADIPOSE BROWNING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC DISORDER; MOUSE; NONHUMAN; SPECIES DIFFERENCE; WHITE ADIPOSE TISSUE; ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HAPLORHINI; METABOLISM; OBESITY; SUBCUTANEOUS FAT;

MACACA MULATTA; MUS;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; HAPLORHINI; HUMANS; MICE; MICRORNAS; OBESITY; SUBCUTANEOUS FAT; TRANSCRIPTOME;

EID: 84940104461     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21153     Document Type: Article

References (35)

1. Virtanen KA, Lidell ME, Orava J, et al., Functional brown adipose tissue in healthy adults. N Engl J Med 2009; 360: 1518-1525.
2. Barbatelli G, Murano I, Madsen L, et al., The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab 2010; 298: E1244-E1253.
3. Diaz MB, Herzig S, Vegiopoulos A., Thermogenic adipocytes: from cells to physiology and medicine. Metabolism 2014; 63: 1238-1249.
4. Rajan S, Gupta A, Beg M, et al., Adipocyte transdifferentiation and its molecular targets. Differentiation. 2014; 87: 183-192.
5. Fu J, Li Z, Zhang H, et al., Molecular pathways regulating the formation of brown-like adipocytes in white adipose tissue. Diabetes Metab Res Rev. 2015; 31: 433-452.
6. Cohen P, Levy JD, Zhang Y, et al., Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 2014; 156: 304-316.
7. Bartelt A, Heeren J., Adipose tissue browning and metabolic health. Nat Rev Endocrinol 2014; 10: 24-36.
8. Gimeno RE, Moller DE., FGF21-based pharmacotherapy-potential utility for metabolic disorders. Trends Endocrinol Metab 2014; 25: 303-311.
9. Kharitonenkov A, Shiyanova TL, Koester A, et al., FGF-21 as a novel metabolic regulator. J Clin Invest 2005; 115: 1627-1635.
10. Xu J, Stanislaus S, Chinookoswong N, et al., Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models-association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab 2009; 297: E1105-E1114.
11. Gaich G, Chien JY, Fu H, et al., The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 2013; 18: 333-340.
12. Fisher FM, Kleiner S, Douris N, et al., FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 2012; 26: 271-281.
13. Lee P, Linderman JD, Smith S, et al., Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab 2014; 19: 302-309.
14. Luo Y, McKeehan WL., Stressed liver and muscle call on adipocytes with FGF21. Front Endocrinol (Lausanne) 2013; 4: 194.
15. Ding X, Boney-Montoya J, Owen BM, et al., betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab 2012; 16: 387-393.
16. Adams AC, Yang C, Coskun T, et al., The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol Metab 2012; 2: 31-37.
17. Muise ES, Souza S, Chi A, et al., Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21. PLoS One 2013; 8: e73011.
18. Mu J, Pinkstaff J, Li Z, et al., FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents. Diabetes 2012; 61: 505-512.
19. Qatanani M, Tan Y, Dobrin R, et al., Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients. Diabetes 2013; 62: 855-863.
20. Owen BM, Ding X, Morgan DA, et al., Fgf21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 2014; 20: 670-67.
21. Markan KR, Naber MC, Ameka MK, et al., Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes. 2014; 63: 4057-4063.
22. Tan BK, Chen J, Adya R, Randeva HS,. Phosphoprotein enriched in diabetes gene product (Ped/pea-15) is increased in omental adipose tissue of women with the polycystic ovary syndrome: ex vivo regulation of ped/pea-15 by glucose, insulin and metformin. Diabetes Obes Metab 2011; 13: 181-184.
23. Condorelli G, Vigliotta G, Iavarone C, et al., PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 1998; 17: 3858-3866.
24. Cassese A, Raciti GA, Fiory F, et al., Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. PLoS One 2013; 8: e60555.
25. Tiraby C, Tavernier G, Lefort C, et al., Acquirement of brown fat cell features by human white adipocytes. J Biol Chem 2003; 278: 33370-33376.
26. Wu J, Oström P, Sparks LM, et al., Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150: 366-376.
27. Rosenwald M, Perdikari A, Rülicke T, Wolfrum C,. Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol 2013; 15: 659-667.
28. Seale P, Kajimura S, Yang W, et al., Transcriptional control of brown fat determination by PRDM16. Cell Metab 2007; 6: 38-54.
29. Rosell M, Kaforou M, Frontini A, et al., Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice. Am J Physiol Endocrinol Metab 2014; 306: E945-E964.
30. Soronen J, Laurila PP, Naukkarinen J, et al., Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects. BMC Med Genomics 2012; 5: 9.
31. Fang S, Suh JM, Reilly SM, et al., Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015; 21: 159-65.
32. Liu P-S, Lin YW, Lee B, McCrady-Spitzer SK, Levine JA, Wei LN,. Reducing RIP140 expression in macrophage alters ATM infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance. Diabetes 2014; 63: 4021-4031.
33. Fiory F, Formisano P, Perruolo G, Beguinot F,. Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab 2009; 297: E592-E601.
34. Kim J, Choi YS, Lim S, et al., Comparative analysis of the secretory proteome of human adipose stromal vascular fraction cells during adipogenesis. Proteomics 2010; 10: 394-405.
35. Lehr S, Hartwig S, Lamers D, et al., Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 2012; 11: M111.010504.